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Schematic	 diagrams	 of	 HIV-1	 and	 influenza	 virus	 fusion	 and	 entry	 processes.	 Major	
conformational	changes	in	the	viral	envelope	glycoproteins	occur	for	fusion	of	both	HIV-1	and	influenza	
virus,	but	the	requirements	for	fusion	differ,	as	do	the	viral	target	types	(not	shown).	For	HIV-1,	gp120	



















































































































































































































































Step	 Flow	Rate	(mL/min)	 Time	(sec)	Reservoir	→	PD	 10mL/min	 9±6.5	Reservoir	→	PD	 8.0mL/min	 10±10.4	Reservoir	→	PD	 6.0mL/min	 13±19.5	Reservoir	→	PD	 4.0mL/min	 16±15.3	
Step	 Flow	Rate	(mL/min)	 Time	(sec)	PD	→	Entrapment	Dock	 2mL/min	 12	PD	→	Entrapment	Dock	 1.75mL/min	 14	PD	→	Entrapment	Dock	 1.50mL/min	 16	PD	→	Entrapment	Dock	 1.25mL/min	 19	
Step	 Time	(sec)	Injection	procedure	 User	dependent:	10±3	
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3.5	 Quantitative	Assessment	of	Animal	Health	The	condition	of	each	individual	zebrafish	was	assessed	after	it	passed	through	the	system.	This	assessment	was	based	on	both	functional	and	morphological	criteria.	At	all	flow	rates	(2mL/min,	1.75mL/min,	1.5mL/min,	1.2mL/min),	heartbeat,	touch-response,	structural	integrity	of	the	yolk	sac	and	melanocytes,	were	evaluated	and	compared	to	a	control	sample.	The	larvae	in	the	control	setup	(same	age)	were	aspirated	in	an	unobstructed	tube	spanning	the	length	of	travel	encountered	by	larvae	in	the	experimental	setup.			
3.5.1		 Procedure		 The	zebrafish	from	the	tests	described	in	section	3.4	were	collected	and	viewed	under	a	microscope	to	evaluate	the	following	parameters:	survival	(heartbeat)	and	morphology	(structural	integrity	of	the	yolk	sac	and	melanocytes).	The	following	data	were	recorded	in	Figure	18.		
3.5.2	 Results		 At	all	of	the	flow	rates	used,	100%	of	the	larvae	survived	(n=100)	for	at	least.	Tearing	of	the	yolk	sac	was	never	observed.	At	the	highest	initial	flow	rate	of	2mL/min,	48%	of	the	larvae	exhibited	morphological	abnormalities,	specifically	slight	distortion	of	melanocytes	along	the	tail	and	of	the	yolk	extension,	Figure	18.	With	the	slightly	slower	initial	aspiration	rates	of	1.75mL/min,	all	health	criteria	matched	those	of	the	controls.			
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Figure	18:	Comparison	of	morphological	abnormalities	of	experimental	zebrafish,	at	
different	flow	rates,	with	a	control	zebrafish.	The	red	arrows	show	distortions	of	the	
melanocytes	and	the	highlighted	region	shows	distortions	of	the	eye	and	the	yolk.			
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Figure	19:	Quantitative	assessment	of	zebrafish	health	at	different	flow	rates	(n=100)	
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CHAPTER	4	
		
SUMMARY,	CONCLUSIONS	AND	FUTURE	WORK	
4.1 		 Summary	A	device	to	accelerate	experiments	involving	microinjection	of	large	numbers	of	larvae	was	designed	and	fabricated	using	inexpensive	rapid	prototyping	techniques.		Chapter	1	introduces	the	influenza	A	virus	and	describes	important	aspects	of	the	virus,	including	its	genetics,	distribution,	transmission	and	clinical	symptoms	of	the	disease	that	it	causes.	This	chapter	also	places	emphasis	on	current	IAV	research	advancements	and	reviews	the	use	of	animal	models	for	infectious	disease	research.		Chapter	2	describes	the	device	components	separately	and	reviews	prototyping	methods,	modes	of	device	function	and	supporting	control	software.	The	device	specifications	and	parameters	are	also	highlighted	in	this	chapter.	Chapter	3	presents	efficacy	tests	of	the	main	components	of	the	system.		
4.2			 Conclusions			 A	fully	functional	zebrafish	immobilization	device	was	designed,	fabricated,	and	tested.	48-72	hpf	zebrafish	larvae	were	successfully	immobilized	within	a	3D	printed	dock.	The	experimental	test	setup	allowed	manipulation	of	the	volumetric	flow	rate	within	the	tubes,	pressure	from	the	air	compressor	used	to	create	air	bubbles	in	reservoir	1,	voltage	within	the	optical	detection	system	and	the	overall	device	output	frequency.	The	loading	stage	was	improved	with	the	addition	of	the	bubbler	to	reservoir	1.	This	played	a	major	role	in	distributing	larvae	evenly	within	the	chamber	during	operation.	
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	 Automation	of	the	system	enhanced	test	reproducibility	by	reducing	the	chances	for	human	error.	The	optical	detection	system	proved	effective	(see	waveform	chart,	Figure	16.	Individual	larvae	were	successfully	identified	by	the	detection	system	with	100%	precision	(no	false	positives).	The	control	software	traced	the	recorded	voltage	readings	that	registered	below	the	basal	reading;	moreover,	the	comparator	increased	the	data	acquisition	rate	two-fold,	from	62	Hz	to	124	Hz.		 One	of	the	most	challenging	aspects	of	the	project	was	the	fabrication	of	the	immobilization	dock.	The	3D	printer	that	was	used	for	this	project	deposited	support	material	within	the	channels	and	no	method	used	to	remove	the	material	was	successful.	By	developing	the	split	design	technique,	I	eliminated	this	problem	by	exposing	the	channels	for	simplified	post-print	processing.	The	tests	of	the	entrapment	dock	were	successful,	i.e.	after	running	100	cycles	through	the	dock	at	various	flow	rates:	48%	of	larvae	(n=25)	were	immobilized	without	any	deformation	at	2mL/min,	76%	of	larvae	(n=25)	were	immobilized	without	any	deformation	at	1.75mL/min,	100%	of	larvae	(n=25)	were	immobilized	without	any	deformation	at	1.50mL/min,	100%	of	larvae	(n=25)	were	immobilized	without	any	deformation	at	1.25mL/min.		
4.3			 Future	Work	At	this	stage	of	device	development,	adjusting	the	flow	rate	within	the	system	during	certain	parts	of	a	given	cycle	can	alter	the	frequency	of	the	device’s	output.	In	spite	of	the	automation	incorporated	into	the	device,	the	user	must	manually	trigger	
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the	control	program	to	execute	certain	commands	such	as	when	to	inject	the	specimen.	By	adding	a	minimal	number	of	steps	to	the	existing	control	program,	an	automatic	injector	equipped	with	a	translation	stage	could	be	incorporated	into	the	design	to	reduce	the	need	for	manual	input.	Furthermore,	a	recovery	system	could	easily	integrated	toward	the	end	of	the	device	to	receive	the	injected	larvae	after	ejection	from	the	system.	Ultimately,	the	device	will	provide	a	seamless	user	interface	that	requires	minimal	user	intervention.	By	depositing	a	known	number	of	zebrafish	larvae	into	the	input	reservoir,	and	inputting	the	dosage	of	the	compound	or	chemical	under	study,	the	device	will	be	able	to	inject	and	dispense	larvae	for	analysis.	Microsystems	designed	for	cell-based	studies	or	applications	such	as	this	one	require	fluid	handling.	Flow	within	these	systems	inevitably	generates	fluid	shear	stress	that	may	adversely	affect	the	health	of	the	organisms	under	study.	Simple	assays	of	specimen	viability	and	morphology	were	used	in	this	project	to	detect	any	gross	disturbances	to	larval	anatomy	and	physiology.	However,	it	will	be	beneficial	to	specifically	evaluate	physiological	implications	of	fluid	shear	stress	within	the	tubes	and	the	entrapment	dock.	Varma	et	al.	at	Massachusetts	Institute	of	Technology	explored	a	useful	technique	that	can	assist	us	with	understanding	the	fluid	dynamics	within	this	device.	It	involves	using	a	genetically	encoded	cell	sensor	that	fluoresces	in	a	quantitative	fashion	upon	encountering	fluid	shear	stress	(FSS)98.	Varma	et	al.	chose	a	widely	used	cell	line	(NIH3T3s)	and	created	a	transcriptional	cell-sensor	that	fluoresces	when	transcription	of	a	relevant	FSS-induced	protein	is	initiated.	The	sensor	pathway	specificity	and	functionality	were	
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verified	by	noting	induced	fluorescence	in	response	to	chemical	induction	of	the	FSS	pathway,	seen	both	through	microscopy	and	flow	cytometry.	In	addition,	these	novel	cell	sensors	can	be	induced	with	a	range	of	FSS	intensities	and	durations,	with	a	limit	of	detection	of	2	dynes/cm2	when	applied	for	30	minutes,	making	it	more	versatile	in	simulating	several	microfluidic	flow	conditions.	Undertaking	the	improvements	discussed	above	will	enable	for	a	more	seamless	operation	of	this	device	and	possibly	pave	the	way	for	subsequent	engineering	systems	with	wide	applications	in	the	microsystems	community.																
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APPENDIX	A	
ZEBRAFISH	HUSBANDRY	Zebrafish	were	housed	at	the	University	of	Maine	Zebrafish	Facility	in	recirculating	systems	where	the	water	temperature	was	maintained	at	28°C	with	a	total	system	flow	rate	of	150	liters/min.	Zebrafish	were	maintained	in	accordance	with	the	Institutional	Animal	Care	and	Use	Committee	standards	of	the	University	of	Maine.	Fertilized	zebrafish	eggs	are	collected	according	to	methods	proposed	by	Phennecie	at	the	University	of	Maine	Zebrafish	Facility99.	Collected	eggs	are	raised	for	24	hours	at	28.0	̊C	in	100mm-diameter	petri	dishes	half	full	of	egg	water,	60µg/L	Instant	Ocean	Salts	in	purified	reverse	osmosis	water.	No	more	than	100	eggs	were	raised	in	one	100mm-diameter	petri	dish	at	a	time.		At	24	hours	post	fertilization,	egg	water	is	replaced	in	each	petri	dish.	Chorions	are	removed	from	the	embryos	by	hand	and	discarded	as	biological	waste.	Live	embryos	are	stored	at	28.0	̊C	until	the	following	day.		At	48hpf,	embryos	are	motile.	Egg	water	is	replaced	in	each	petri	dish	and	dead	embryos	are	removed	from	the	container.	Embryos	are	stored	at	28.0	̊C	overnight.		At	72hpf,	specimens	are	considered	larvae.	Zebrafish	egg	water	is	replaced	and	specimens	are	used	as	needed	in	further	laboratory	procedures.				 Zebrafish	were	euthanized	in	a	600µg/L	concentrated	stock	of	Tricane	for	30min	and	fixed	to	minimize	the	amount	of	larvae	needed	for	repeated	testing.	Fish	are	removed	from	anesthetic	and	placed	in	fixative	solution	of	1.5%	gluteraldehyde,	0.5%	para-formaldehyde,	50mM	PBS	(phosphate	buffered	saline)	for	long	term	storage100.	Larvae	were	fixed	for	at	least	12	hours	prior	to	use.	For	flow	testing,	
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chemically	fixed	fish	were	removed	from	fixative	solution	and	placed	in	egg	water	with	no	more	than	0.25%	gelatin	to	minimize	larval	adhesion	to	tubing.		For	procedures	involving	live	specimens,	larvae	are	anaesthetized	in	a	200µg/mL	solution	of	tricane	with	no	more	than	0.25%	gelatin	added	to	minimize	specimen	adhesion	to	tubing.	Fish	were	aspirated	through	the	device	in	the	anesthetic	gelatin	solution.		
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APPENDIX	B		
VALVE/SYRINGE	PUMP	CONTROL	MAP	SETUP:	MyDAQ	DIO	channels	(0-5)	
• Input	–	laser	detector	(detected	fish=1,	nothing	detected=0)	
• Output	–	valve	1	(open=1,	close=0)	
• Output	–	valve	2	(open=1,	close=0)	
• Output	–	valve	3	(open=1,	close=0)	
• Output	–	valve	4	(open=1,	close=0)	
• Output	–	valve	5	(open=1,	close=0)	
• Output	–	syringe	pump	direction	(inject=1,	withdraw=0)	
• Output	–	syringe	pump	start/stop	(start=1,	stop=0)		Program	Commands:	
• All	valves	closed,	pump	stopped	
• Set	pump	to	withdraw	mode	
• Close	valve	2,	Close	valve	4,	Close	valve	5(should	be	closed	already)	
• Open	valve	1	and	valve	3	
• Start	pump	1	
• Monitor	detector	
	 If	positive	detect	→	stop	pump,	close	valve	1,	close	valve	3,	open	valve	2,	open	valve	3	set	pump	to	inject,	start	pump	
• Pump	injects.	Duration:	(input	value)	seconds	→	stop	pump,	valve	2	close	
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• Inject.	Duration:	(input	value)	seconds	
• Open	valve	4,	open	valve	5	
• 	Start	pump	2	(infuse)	
• Wait	for	fish	to	flush	out.	Duration:	(input	value)	seconds	
• Stop	pump	
• Close	valve	5	
• Go	to	Step	1		
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APPENDIX	C		
MATERIALS	LIST	Pump	System	Materials:	
	 Tygon	Micro	Bore	Tubing,	Part	#:	TGY-030.	Component	Supply	Co.	
	 Silicone	Tubing,	Part	#:	SCT-063A.	Component	Supply	Co.	
	 BD	60mL	Syringe,	Part	#:	309654.	Becton,	Dickinson	and	Company.	
	 New	Era	NE-1000X	Programmable	Syringe	Pump	
	 2-way	normally	closed	solenoid	pinch	valve,	Part	#	98302.	Cole	Palmer	Instrument	Company,	LLC.	
	 Aqua	Culture	Single	Outlet	Aquarium	Air	Pump,	Part	#	0079285405132		Optical	Detection	Materials	
	 5mm	transparent	cylinder	head	photodiode,	Part	#	LLSO5-A.	Senba	Optical	Electrical	Co.,	Ltd		
	 4.5V	650	nm	red	laser	diode	module,	Part	#	01444878.	LightInTheBox	Co.,	Ltd		
	 PROCELL	1.5V	dry	cell	batteries,	Part	#	PC1500.	Duracell	Inc.		Entrapment	Dock	Materials	
	 Objet30	Rapid	Prototyping	System,	SUP705	Support	Material	(Water	Jet	Removable).	Stratasys	Ltd.	
	 Custom	Stage	Mount	
	 MakerBot	Replicator	Desktop	3D	Printer,	PLA	Filament.	MakerBot	Industries,	LLC.	
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	Electronics	
	 National	Instruments	myDAQ	Unit	
	 SC5	Five-Channel	Solenoid	Controller/Driver.	RW	Automations,	LLC.	
	 SolidEdge	ST7.	Siemens	Product	Lifecycle	Management	Software	Inc.	
	 National	Instruments	LabVIEW	2016.	National	Instruments.		 	
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